Form 4: BlackSky Director James R. Tolonen Acquires Shares in Lieu of Cash Compensation

Sentiment:

SEC Form 4


Director James R. Tolonen acquired 2,085 shares of BlackSky Technology Inc. Class A Common Stock on December 31, 2024, in lieu of cash compensation.

Summary

  • On December 31, 2024, James R. Tolonen, a director of BlackSky Technology Inc., acquired 2,085 shares of Class A Common Stock.
  • The acquisition was made in lieu of cash compensation under the Issuer's Outside Director Compensation Policy for the quarter ended December 31, 2024.
  • The number of shares was calculated based on the closing price of BlackSky's Class A Common Stock on December 31, 2024.
  • Following the transaction, Tolonen directly owns 60,453 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine insider transaction. The director taking shares instead of cash could be seen as a slightly positive signal.

Positives

  • A director taking shares in lieu of cash compensation can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Directors often receive stock as part of their compensation packages.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it is a standard part of director compensation.

Key Dates

DateDescription
12/31/2024Date of transaction: James R. Tolonen acquired 2,085 shares of Class A Common Stock in lieu of cash compensation.
12/31/2024Date of report: Filing date of the SEC Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.